Pancreatic cancer mortality in China from 2004 to 2021: an in-depth analysis of age, gender, and regional disparities
Pancreatic cancer mortality in China has shown significant increases over the past 18 years, especially among males, older adults, and rural populations. The findings highlight the urgent need for targeted public health interventions to address gender- and age-specific risks, as well as healthcare access inequalities in less developed regions. Future research should focus on gathering more granular, individual-level data to better understand the complex interplay of risk factors and inform more effective prevention and treatment strategies.
Authors
- Qiuping Chen (ORCID: https://orcid.org/0000-0001-9132-0912)
- Zhengnan Shen (ORCID: https://orcid.org/0000-0003-0276-7742)
- Hai Hu (ORCID: https://orcid.org/0000-0002-5348-5641)
- Quansheng Feng (ORCID: https://orcid.org/0000-0003-3437-8987)
- Xin Ding (ORCID: https://orcid.org/0000-0003-1322-660X)
- Rui He (ORCID: https://orcid.org/0009-0002-8200-703X)
- Baixue Li (ORCID: https://orcid.org/0000-0002-1459-8803)
- Zhenglong Zheng
Institutions
- Chengdu University of Traditional Chinese Medicine (CN)
Publication Details
- Journal
- BMC Cancer
- Published
- 2025-05-19
- DOI
- https://doi.org/10.1186/s12885-025-13863-0
- Citations
- 3
- Primary Topic
- Pancreatic and Hepatic Oncology Research
- Type
- article
- Field-Weighted Citation Impact
- 3.14